BioNTech May Be the Next Moderna. Even if it Isn't, the Stock Is a Buy.

BioNTech May Be the Next Moderna. Even if it Isn't, the Stock Is a Buy.

来源:Barrons发布于 2026-11-13

BioNTech has multiple catalysts that could generate a rally of 35% for the stock.

相关标的:BNTX

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。